SBIR-STTR Award

Development Of Heartlander As An Epicardial Injection Delivery System
Award last edited on: 1/30/12

Sponsored Program
SBIR
Awarding Agency
NIH : NHLBI
Total Award Amount
$98,519
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Bryan P Bergeron

Company Information

Heartlander Surgical Inc (AKA: Enhanced Medical Systems LLC)

90 Wildwood Drive
Westwood, MA 02090
   (781) 320-9601
   N/A
   www.heartlandersurgical.com
Location: Single
Congr. District: 08
County: Norfolk

Phase I

Contract Number: 1R43HL114022-01
Start Date: 9/20/11    Completed: 3/31/12
Phase I year
2011
Phase I Amount
$98,519
Numerous innovative therapies that must be delivered into the heart wall are now under development. These therapies typically require precise placement of a precise measure of an injectable substance and are intended to be delivered by minimally invasive means to minimize patient trauma. Unfortunately, traditional approaches for delivering such therapies, such as intracoronary and endocardial catheters and flexible endoscopy, have proven insufficient. The HeartLander epicardial delivery system has shown great potential for addressing this issue in its research outcomes to date. This proposed effort will take the HeartLander research prototype and translate it to be appropriate for meeting clinical needs by providing it with needed functional and safety capabilities.

Public Health Relevance:
By developing the HeartLander epicardial delivery system to have the needed clinical and safety characteristics to allow a host of innovative therapies to be reliably injected into the heart wall with minimal invasiveness to the patient, a spectrum of vexing cardiac conditions will be treatable that are now not well handled.

Thesaurus Terms:
Address;Basic Research;Basic Science;Body Tissues;Cardiac;Cardiac Valves;Catheters;Characteristics;Clinical;Development;Effectiveness;Endoscopy;Family Suidae;Funding;Heart;Heart Valves;Heart Failure;Injectable;Injection Of Therapeutic Agent;Injections;Innovative Therapy;Loinc Axis 4 System;Location;Measures;Mechanical Aspiration;Mechanics;Movement;Myocardial;Myocardium;Nih;National Institutes Of Health;Natural Regeneration;Needles;Outcomes Research;Patients;Performance;Pericardial Sac Structure;Pericardium;Phase;Pigs;Progenitor Cells;Regeneration;Research;Safety;Specific Qualifier Value;Specified;Staging;Stem Cells;Suction;Suction Drainage;Suidae;Surface;Swine;System;Tissues;Translating;Trauma;United States National Institutes Of Health;Walkers;Work;Body Movement;Cardiac Failure;Cardiac Muscle;Developmental;Experiment;Experimental Research;Experimental Study;Flexibility;Flexible;Foot;Heart Muscle;In Vivo;Mechanical;Meetings;Minimally Invasive;Porcine;Prototype;Regenerate;Research Study;Suid

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----